Personalized medicine market to exceed $1 trillion by 2034, driven by genomics and AI advances.

The personalized medicine market is projected to grow from USD 524 billion in 2025 to over USD 1 trillion by 2034, fueled by advances in genomics, biomarker diagnostics, and AI-powered data analytics. This growth is driven by rising chronic diseases and cancer, increasing demand for targeted therapies, and expanding digital health integration. North America leads the market, supported by strong healthcare infrastructure and government backing, while Asia-Pacific emerges as a fast-growing region. Key companies include Novartis, Pfizer, Roche, and Illumina, with innovations in gene therapy and personalized nutrition shaping the future of healthcare.